← SynDRA
PARGYLINE
SynDRA canonical compound SYN0001347 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | MAOB |
| Mechanism of action | Monoamine oxidase inhibitor |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- MAOB
- MAOA
- Aldh2
- Maoa
- Maob
Mechanisms of action (all sources)
- Monoamine oxidase inhibitor
- MAOA INHIBITOR
- MAOB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD2
- ABCG2
- PDE3A
- OPRM1
- OPRK1
- OPRD1
- MPHOSPH8
- LMNA
- KMT5A
- HRH3
- KDM1A
- KCNH2
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- PDE4A
- PDE4D
- PGR
- PRMT1
- PTGS1
- PTH1R
- PYCR1
- SAMHD1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- SMN1
- TBXA2R
- TRPV1
- TSHR
- HTR1A
- HRH2
- ACHE
- CHRM3
- ADORA1
- ADRA1A
- ADRA2A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Monoamine Oxidase Inhibitors
ATC classes
- C02K · OTHER ANTIHYPERTENSIVES
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- EUTONYL
- EUTRON
- pargyline hydrochloride
- eutonyl
- N-Methyl-N-benzylpropynylamine
- pargylamine
- pargylin
- supirdyl
- pargyline HCl
- Pargilina
- Eutron
- Benzylmethylpropargylamine
- Benzylmethylpropynylamine
- Eudatin
- Methylbenzylpropynylamine
- Paragyline
- Pargylamine
- Pargylin
- Pargylinum
- Supirdyl
- A 19120
- MO 911
- Pargilina [INN-Spanish]
- Pargyline (INN)
- Pargyline [INN:BAN]
- Pargylinum [INN-Latin]
- Benzyl-methyl-2-propinylamin
- Benzyl-methyl-2-propinylamin [Czech]
- N-Methyl-N-propargylbenzylamine
- N-Methyl-N-2-propynylbenzylamine
- N-Benzyl-N-methyl-2-propynylamine
- N-Benzyl-N-methyl-2-propyn-1
- N-Benzyl-N-methyl-2-propyn-1-amine
- N-benzyl-N-methylprop-2-yn-1-amine
- N-methyl-N-(phenylmethyl)prop-2-yn-1-amine
- Benzenemethanamine, N-methyl-N-2-propynyl-
- benzyl(methyl)(prop-2-yn-1-yl)amine
- 9MV14S8G3E
Look up PARGYLINE in the interactive SynDRA portal →